ClinicalTrialsFinder

22q11.2 Deletion Syndrome Clinical Trials in Atlanta, Georgia

1 recruitingAtlanta, Georgia

Showing 1–1 of 1 trials

Recruiting

The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment

AneuploidyDown Syndrome (Trisomy 21)22q11.2 Deletion Syndrome+4 more
BillionToOne Inc.1,000 enrolled6 locationsNCT07643896